Search results
Author(s):
Arif A Khokhar
,
Jonathan Curio
,
Matthew Hammond-Haley
,
et al
Added:
4 days ago
Author(s):
Vlasis Ninios
Added:
3 weeks ago
PCR London Valves 2025 - Dr Vlasis Ninios (Interbalkan European Medical Center, GR) discusses one-year outcomes from the AltaValve Early Feasibility Study, evaluating a novel atrial fixation system for transcatheter mitral valve replacement in patients with severe mitral regurgitation.This prospective, single-arm, multicenter study enrolled high surgical risk patients with moderate to severe or…
View more
Author(s):
Jonathan Schwartz
Added:
3 weeks ago
PCR London Valves 2025 - In this interview, Dr Jonathan Schwartz, leading structural interventional cardiologist at the Sanger Heart and Vascular Institute, Lake Forest University (Charlotte, NC, US) shares his insights into the evolving landscape of transcatheter tricuspid valve therapies.Dr Schwartz examines the latest real-world and clinical trial evidence for the EVOQUE and TriClip systems,…
View more
Author(s):
Pier Pasquale Leone
,
Azeem Latib
Added:
2 months ago
Author(s):
Volker Rudolph
,
Sam Dawkins
,
Ali Vazir
,
et al
Start date:
Dec 03, 2025
Severe tricuspid regurgitation (TR) remains an under-recognised and under-treated condition, stressing the importance of timely identification and referral to improve clinical outcomes.In this interactive session, Prof Marianna Adamo (University of Brescia, Brescia, IT) and Prof Volker Rudolph (Heart and Diabetes Center NRW, Bad Oeynhausen, DE) moderate an expert faculty of Prof Marta Sitges …
View more
Author(s):
Santiago Garcia
Added:
5 months ago
New York Valves 2025 -Dr Santiago Garcia (The Christ Hospital, Cincinnati, OH, US) joins us to discuss outcomes from an observational study investigating early outcomes of the Navitor self-expandable transcatheter valve with intra-annular leaflet position. Approximately 3,000 patients with severe, symptomatic aortic stenosis, high surgical risk and tricuspid anatomy were enrolled in the study and…
View more
Author(s):
Added:
5 months ago
New York Valves 25 - Quantitative findings from Tri-QOL showed a strong correlation between tricuspid regurgitation (TR) reduction and KCCQ improvement after transcatheter tricuspid valve intervention (TTVI).Dr Suzanne Arnold (Saint Luke's Mid America Heart Institute, Kansas City, US) discusses findings from a quantitative analysis from the Tri-QOL study which aimed to assess the optimal result…
View more
Author(s):
James Krzowski
,
Jonathan Weir-McCall
,
Luigia D’Errico
,
et al
Added:
7 months ago
Author(s):
Paul Grayburn
Added:
5 months ago
New York Valves 2025 - Echocardiographic outcomes from the TRISCEND II substudy reinforce the effectiveness of TTVR compared to medical therapy alone at one year post transcatheter tricuspid valve replacement (TTVR).Dr Paul Grayburn (Baylor Scott and White Research Institute, Dallas, US) joins us to discuss echocardiographic outcomes one year post TTVR from the TRISCEND II substudy which…
View more
Making the Right Referral
Video Series